Avoid voriconazole in transplant patients at risk for skin cancer
SAN FRANCISCO – Voriconazole increased the risk of squamous cell carcinoma by 73% in a review of 455 lung transplant patients at the University of California, San Francisco.
The increase was for any exposure to the drug after transplant (adjusted hazard ratio, 1.73; P = .03). The...
Source: Skin and Allergy News - Category: Dermatology Tags: FPN Conferences IMN Conferences SAN Conference News SN Conferences SN News FPN News FPN Dermatology FPN Oncology HOSP News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Conferences | Dermatology | Lung Transplant | Skin | Skin Cancer | Squamous Cell Carcinoma | Transplant Surgery | Transplants